Authors
Latest:
Considerations for the Effective Rollout of DCTs at a Global ScaleFor effective rollout on a global scale, sponsors must address and develop a plan around known challenges including recruitment, sit adoption, and technology integration.
Latest:
Regulatory Data: How Technology Can Help ClinOps SurviveClinical operations professionals, burdened by lack of data standardization, turn to technology in hopes of streamlining regulatory processes for the future.
Latest:
Guide to Incorporating Modern Research Tools and TechniquesThis piece offers a practical assessment of leveraging various decentralized methodologies and technologies.
Latest:
Adapting Site Selection for Clinical Trial Decentralization and the Future LandscapeSites not expected to fade away even as DCTs continue to grow past COVID-19.
Latest:
Accelerating Clinical Trial ActivationThe activation of each clinical trial involves hundreds of tasks, along with many dependencies and handoffs, some of which may be automated, but many require manual processes.
Latest:
Establishing Metrics and Standardization for Non-CRF Data in EDCWhile Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Latest:
Advancing ICU Care with eConsentComplicated process of consenting ICU patients can be simplified with a well-designed eConsent platform.
Latest:
Is Trust the Secret Ingredient for Digital Product Success?To rebuild trust, companies should focus on transparent, neutral content incorporating medical expertise and regularly seeking HCP feedback.
Latest:
Virtual Trials Save the DayVirtual trials tools are usually selected early in the protocol development stage, however, due to the COVID-19 crisis, regulators are encouraging sponsors to consider integrating virtual elements into clinical trials already in progress.
Latest:
Steps Toward Diversity in Clinical Trials: Building Authentic TrustBuilding authentic trust lays at the heart of creating more patient-centric trials.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
A Cross-Sectional Study of Patient Perspectives on Clinical Trial Participation in a Large Community-Based Research FacilityAn overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.
Latest:
Impact of COVID-19 on Phase I Clinical ActivitiesLife sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
Latest:
COVID-19 Will Have a Heterogeneous Impact on Clinical Trials, BiopharmasA discussion of how the coronavirus pandemic will have a multitude of impacts on the conduct of trials, as well as on the industry itself.
Latest:
Remembering That TIME Magazine Issue; Celebrating Progress in Patient EngagementLooking to the past reminds industry of great strides taken in clinical research for patients.
Latest:
Unlocking Oncology Insights - Innovations in Evidence Generation With RWE SolutionsThe rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Machine learning and large language models can be used to quickly identify information, supporting custom integrated real-world evidence solutions to make informed decisions.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and DevelopmentBest practices for assessing publications.
Latest:
Using Machine Learning to Predict Placebo Response and Increase Clinical Trial SuccessA look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Latest:
Aligning Patient Burden with Planetary BurdenHow making trial participation easier can reduce the impact on the environment.
Latest:
How DCT Technology Can Enable Follow-up Clinical StudiesResearch can reveal vital information about treatments in the long run.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
